331PRibociclib (RIB) + fulvestrant (FUL) for advanced breast cancer (ABC): Progression-free survival (PFS) subgroup and tumor response analyses from MONALEESA-3. (23rd October 2018) - Jerusalem, G; Fasching, P A; Martín, M; Pivot, X; Petrakova, K; Bianchi, G V; Nusch, A; Sonke, G S; De La Cruz Merino, L; Vagnon, E; Alam, J; Kong, O; et al.